Rocket Lab is no longer just a launch company. The $8 billion acquisition of Iridium Communications marks a decisive shift into satellite services, handing the firm a network with more than 2.5 million subscribers and a steady stream of recurring revenue. Investors cheered the news, sending shares up 12.38% to €81.70, yet that single session’s gain does little to erase the memory of a brutal June that carved 38% from the stock.
Under the deal, Rocket Lab will pay $54 per Iridium share in a mix of cash and stock. The target is to control the entire space value chain — from building rockets to operating high-margin satellite connectivity for maritime and navigation customers. Analysts view the purchase as a clear path toward predictable earnings in an industry long plagued by lumpy contracts and high capital costs.
Operational firepower that the market overlooked
While the Iridium news dominates the headlines, Rocket Lab’s underlying operations have been strengthening for months. Production of the Electron rocket now runs on an 11-day cycle, and a recent mission for the U.S. Space Force went from notification to launch in just 16 hours and 42 minutes — a record turnaround. First-quarter 2026 revenue surged 63% year-over-year to $200.3 million, and the contract backlog stands at $2.2 billion.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The company also secured three dedicated Electron launches for NASA’s PolSIR and TSIS-2 science missions, set to begin in early 2027 under the space agency’s Venture-Class program, which has a total ceiling of $300 million. Over the weekend, a separate Electron mission from New Zealand successfully deployed a radar satellite for long-time customer Synspective — the tenth consecutive flight for that client.
From correction to catalyst calendar
Despite the operational wins, Rocket Lab’s stock spent June in a deep correction, slipping well below its 50-day moving average before the Iridium announcement snapped the slide. KeyBanc lifted its rating from Hold to Buy following the deal, describing Rocket Lab as the clear number two in commercial launch behind SpaceX. Stifel Nicolaus also raised its price target, citing the growing pipeline. The consensus analyst target sits at $106.92, implying substantial upside from current levels if the correction phase is truly over.
The company’s inclusion in the Nasdaq-100 on June 22 provided a temporary boost, but it was not enough to halt the month-long rout. Now, the focus shifts to two major milestones: the maiden flight of the larger Neutron rocket, scheduled for the fourth quarter of 2026, and the second-quarter earnings report due in August. Between the Iridium acquisition, a bulging order book, and fresh NASA contracts, Rocket Lab has narrative ammunition to win back skeptical investors — but the market will demand proof in the numbers.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from June 29 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 29.
Rocket Lab: Buy or sell? Read more here...
